Dr Rhonda LaFleur | Principal Scientist
Merck Animal Health
- 1992: received Bachelor of Science degree from University of Nebraska - Lincoln
- 1998: received PhD in Molecular Veterinary Biosciences from University of Minnesota
- 1998 to present: leads a team of researchers at Merck Animal Health that develops new or improved vaccines for companion animals
Appearances:
DC Co-conference Day 2 April 4 @ 5:40
Nobivac® canine flu bivalent vaccine
- Merck Animal Health’s response to CIV H3N2 outbreak in Chicago
- CIV H3N2 infection in dogs
- First vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8
- Efficacy study results
- Next steps
Organiser
